XLV241213C144500
- 0.01
- -0.29-96.67%
The Health Care Select Sector SPDR® Fund Newsroom
The murder case has triggered a major transformation in the Industry: a proposed bill in the USA Congress aims to break the Medical Insurance monopoly.
① The CEO of UnitedHealth Insurance, Brian Thompson, was killed, triggering widespread criticism from the American public regarding the Medical Insurance Industry; ② The U.S. Congress is currently reviewing two bills aimed at breaking the monopoly in the Insurance industry, marking the first time lawmakers are introducing policies targeting the Insurance industry since Thompson's murder; ③ Senator Warren stated that the public opinion in the USA should raise awareness among all practitioners.
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Joe Rogan On Public Sympathy For UnitedHealthcare CEO Murder Suspect: Health Insurance A 'Dirty, Dirty Business'
Thursday Ends in Index Declines | Wall Street Today
Unpacking the Latest Options Trading Trends in Amgen
Stocks Slip On Hot Inflation Data, Adobe Tumbles, Natural Gas Hits 1-Year High: What's Driving Markets Thursday?
Novo Nordisk's Ozempic Label Expansion Snags Approval From European Drug Regulator's Advisory Panel
"Person of the Year" Trump rings the opening bell at the NYSE, emphasizing that "the stock market is everything."
On December 12, the elected President Trump was named Time Magazine's Person of the Year for 2024, ringing the opening bell at the NYSE that day; Trump rang the bell with the CEO of ICE and the CEO of Time Magazine, along with the president of the NYSE, while the CEOs of companies such as Goldman Sachs and Citigroup were present; Trump promised an "unprecedented economy," planned to increase oil drilling to reduce inflation, and committed to lowering the corporate tax rate to 15%.
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
What the Options Market Tells Us About UnitedHealth Group
Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflix
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Traders Pull Back in Anticipation of More Inflation Data
Leading And Lagging Sectors For December 12, 2024
Jim Cramer Bullish On Netflix Nearing $1,000 And AMD's 'Cheap' Valuation Despite Nvidia Dominance
Trump is reportedly set to ring the bell at the NYSE today. What does it signify?
① According to media reports, the USA's incoming president Trump will go to the NYSE on Thursday to ring the opening bell and deliver a speech; ② There are reports that Trump will be named Time Magazine's Person of the Year for 2024, but this has not yet been confirmed by Time; ③ Since Trump's announcement of victory, the three major US stock indices have risen repeatedly, with the market encouraged by promises of tax cuts and deregulation.
The NASDAQ broke through 0.02 million points for the first time, Tesla led a group of tech giants to a new high, and Bitcoin climbed to 0.1 million dollars
The Dow and Apple fell, the Nasdaq rose nearly 2%, Tesla and Google rose nearly 6%, while Meta, Amazon, and Netflix all reached new highs. NVIDIA rose over 3%, Broadcom rose nearly 7%, Super Micro Computer once dropped over 8%, the decline of Chinese concepts narrowed, and Fangdd Network turned to rise over 11%. The U.S. November CPI confirms interest rate cut bets for next week, with a pause on rate cuts expected in January next year. The dollar and U.S. Treasury yields rebounded in a V-shape, while spot Gold reached its highest level in five weeks. The yen plunged below 152, while the offshore yuan once dropped over 300 points, falling below 7.29 yuan. After a significant interest rate cut by the Bank of Canada, the Canadian dollar and Canadian bond yields turned to rise, and oil prices increased by about 2%.
Nasdaq Surges Past 20,000 for the First Time, Powered by Tech Giants | Wall Street Today
Johnson & Johnson Analyst Ratings